NIR Stimulus-Responsive PdPt Bimetallic Nanoparticles for Drug Delivery and Chemo-Photothermal Therapy

The combination of chemotherapy and phototherapy has attracted increasing attention for cancer treatment in recent years. In the current study, porous PdPt bimetallic nanoparticles (NPs) were synthesized and used as delivery carriers for the anti-cancer drug doxorubicin (DOX). DOX@PdPt NPs were modi...

Full description

Saved in:
Bibliographic Details
Main Authors: Chun Chu (Author), Zhihong Bao (Author), Meng Sun (Author), Xiaowei Wang (Author), Hongyan Zhang (Author), Weiguo Chen (Author), Yang Sui (Author), Ji Li (Author), Yuanyuan Zhuang (Author), Dongkai Wang (Author)
Format: Book
Published: MDPI AG, 2020-07-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_f53259fb1d0a44369c68b45f1d8a28c1
042 |a dc 
100 1 0 |a Chun Chu  |e author 
700 1 0 |a Zhihong Bao  |e author 
700 1 0 |a Meng Sun  |e author 
700 1 0 |a Xiaowei Wang  |e author 
700 1 0 |a Hongyan Zhang  |e author 
700 1 0 |a Weiguo Chen  |e author 
700 1 0 |a Yang Sui  |e author 
700 1 0 |a Ji Li  |e author 
700 1 0 |a Yuanyuan Zhuang  |e author 
700 1 0 |a Dongkai Wang  |e author 
245 0 0 |a NIR Stimulus-Responsive PdPt Bimetallic Nanoparticles for Drug Delivery and Chemo-Photothermal Therapy 
260 |b MDPI AG,   |c 2020-07-01T00:00:00Z. 
500 |a 10.3390/pharmaceutics12070675 
500 |a 1999-4923 
520 |a The combination of chemotherapy and phototherapy has attracted increasing attention for cancer treatment in recent years. In the current study, porous PdPt bimetallic nanoparticles (NPs) were synthesized and used as delivery carriers for the anti-cancer drug doxorubicin (DOX). DOX@PdPt NPs were modified with thiol functionalized hyaluronic acid (HA-SH) to generate DOX@PdPt@HA NPs with an average size of 105.2 ± 6.7 nm. Characterization and in vivo and in vitro assessment of anti-tumor effects of DOX@PdPt@HA NPs were further performed. The prepared DOX@PdPt@HA NPs presented a high photothermal conversion efficiency of 49.1% under the irradiation of a single 808 nm near-infrared (NIR) laser. Moreover, NIR laser irradiation-induced photothermal effect triggered the release of DOX from DOX@PdPt@HA NPs. The combined chemo-photothermal treatment of NIR-irradiated DOX@PdPt@HA NPs exerted a stronger inhibitory effect on cell viability than that of DOX or NIR-irradiated PdPt@HA NPs in mouse mammary carcinoma 4T1 cells in vitro. Further, the in vivo combination therapy, which used NIR-irradiated DOX@PdPt@HA NPs in a mouse tumor model established by subcutaneous inoculation of 4T1 cells, was demonstrated to achieve a remarkable tumor-growth inhibition in comparison with chemotherapy or photothermal therapy alone. Results of immunohistochemical staining for caspase-3 and Ki-67 indicated the increased apoptosis and decreased proliferation of tumor cells contributed to the anti-tumor effect of chemo-photothermal treatment. In addition, DOX@PdPt@HA NPs induced negligible toxicity in vivo. Hence, the developed nanoplatform demonstrates great potential for applications in photothermal therapy, drug delivery and controlled release. 
546 |a EN 
690 |a PdPt bimetallic nanoparticles 
690 |a drug delivery 
690 |a chemo-photothermal therapy 
690 |a anti-tumor effect 
690 |a Pharmacy and materia medica 
690 |a RS1-441 
655 7 |a article  |2 local 
786 0 |n Pharmaceutics, Vol 12, Iss 7, p 675 (2020) 
787 0 |n https://www.mdpi.com/1999-4923/12/7/675 
787 0 |n https://doaj.org/toc/1999-4923 
856 4 1 |u https://doaj.org/article/f53259fb1d0a44369c68b45f1d8a28c1  |z Connect to this object online.